What is it about?
Covers carnitine deficiency,neutral lipid storage disorders,RR-MADD
Featured Image
Why is it important?
both treatment and diagnostic issues are covered
Perspectives
the correlation between ETF-dehydrogenase mutation and treatment response to riboflavin is new and important
Prof Corrado Angelini
Universita degli Studi di Padova Polo Bibliotecario di Scienze Farmacologia e Scienze Farmaceutiche
Read the Original
This page is a summary of: Metabolic lipid muscle disorders: biomarkers and treatment, Therapeutic Advances in Neurological Disorders, January 2019, SAGE Publications,
DOI: 10.1177/1756286419843359.
You can read the full text:
Contributors
The following have contributed to this page
